, /PRNewswire/ -- CellFE Inc., a cell engineering platform company with a novel microfluidic technology for non-viral cell therapy manufacturing, announced today that life science tools executive has been appointed to its Board of Directors. Mr.
Rice previously served as Chairman & CEO at BioLife Solutions, a leading supplier of bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Board member , Investment Director at M Ventures, remarked, "We are thrilled that Mike has joined the CellFE Board as his experience in successfully scaling up a life sciences tool business will be invaluable to the team. We look forward to Mike's contributions during this exciting inflection point for our portfolio company.
" Alla Zamarayeva, CellFE co-founder and CEO, commented, "CellFE's cell engineering platform is increasingly being recognized for its unique non-viral approach to manufacture cell therapies. This recognition is validated as our customers continue to generate compelling performance data. The CellFE team is poised to disrupt cell therapy manufacturing, and we look forward to working with Mike.
His industry expertise will be invaluable as we accelerate our commercial outreach and amplify CellFE's brand awareness and value proposition to pharmaceutical and biotech sectors." Rice offered, "Alla and Todd have built a great team and I'm impressed with the entire leadership group and the progress the company has made in gaining market tracti.